Fierce BioTech

OCTOBER 25, 2023

The AI innovation race is on: Here are three strategies to ensure you’re not left behind | Biotech and pharma companies are using generative AI to improve business operations, marketing performance and research.

Pharma Companies 64

Pharma Companies Marketing Research 64

H1 Blog

MAY 11, 2023

Drive Engagement and Segmentation for Physician Marketing With the proliferation of digital media, marketing in the healthcare industry has shifted from traditional tactics to an omnichannel approach. With an omnichannel approach, pharma marketers can have a better understanding of HCP interests and preferences.

Pharma Companies 52

Pharma Companies Marketing Treatment Pharmaceuticals 52

Fierce BioTech

SEPTEMBER 30, 2024

Fierce Biotech Week Fierce Biotech Week features insights from C-suite and executive leadership at biotech, mid-sized and large pharma companies on emerging trends and market dynamics that will help effectively prioritize R&D spend, optimize drug development and clinical operations, and navigate capital raising and partnering deals.

Pharma Companies 52

Pharma Companies Drug Development Marketing Drugs 52

Fierce BioTech

JULY 25, 2023

How combining datasets from multiple sources can inform and improve commercial strategies Hundreds of rare disease treatments have entered the market over the past decade—thanks largely to a combination of government incentives, strong urging from patient advocacy groups and advances in cell and gene therapies.

Pharma Companies 52

Pharma Companies Government Therapies Disease 52

thought leadership

MAY 29, 2023

Specialty pharma companies are focused on developing drugs for niche markets, such as rare diseases , cancer, and other complex conditions. In this blog post, we'll explore some of the key challenges of specialty pharma drug development project management and discuss strategies for overcoming them.

Drug Development 52

Drug Development Pharma Companies Drugs Disease 52

DrugBank

JUNE 27, 2024

Generic drugs are also an interesting case and are common targets for repurposing due to their established safety profiles and long market presence. They also provide a level playing field for academics, biotech companies, and pharma giants to compete on.

Drugs 98

Drugs Pharma Companies Clinical Trials Computational Chemistry 98

The Pharma Data

NOVEMBER 19, 2020

In the era of “fast-moving products” and digital disruption, pharma companies are battling with customer demand to deliver products to market at increased speed and scale. In this online series, we tackle some of the key challenges affecting manufacturing, data management and R&D in the lab. .

Pharma Companies 52

Pharma Companies Production Marketing Drugs 52

The Pharma Data

NOVEMBER 10, 2020

By employing the services of a CV, the company has access to a fully-managed and outfitted animal research facility that includes supporting services for preclinical rodent research, which gives them complete control over their studies and enables them to keep studies “in-house”. .

Marketing 52

Marketing Science Pharma Companies Research 52

ACTO

SEPTEMBER 11, 2024

The life sciences industry is actively looking for new ways to leverage AI to bring drugs to market faster to patients waiting in need,” said Parth Khanna, CEO of ACTO. Current solutions are almost exclusively focused on marketing, HCP targeting, workflow automation, and performance insight.

Science 52

Science Pharma Companies Production Marketing 52

The Connected Lab

APRIL 8, 2020

The cost to develop a new prescription medicine that gains market approval has gone up 145% to $2.6 It is reported that every one of the major pharmaceutical companies has announced a partnership with at least one AI-based drug development company, but how is AI being used to facilitate drug development? Nature , vol.

Pharma Companies 52

Pharma Companies Laboratories Drugs FDA Approval 52

The Pharma Data

JUNE 6, 2025

Global Pharmaceutical Contract Sales Outsourcing Market to Reach $24.8 Billion by 2030: Strategic Insights, Regional Trends, and Technological Shifts Reshaping the Landscape The global pharmaceutical contract sales outsourcing (CSO) market is entering a transformative phase, with its value expected to grow from $17.3 In the U.S.,

Pharmaceutical Companies 40

Pharmaceutical Companies Compliance Pharmaceuticals International 40

The Pharma Data

JANUARY 24, 2021

.–( BUSINESS WIRE )– Faze Medicines , a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular condensates, today announced that it has appointed Philip Vickers, Ph.D., Preclinical and clinical programs at Northern Biologics were acquired by big pharma companies in 2020.

Pharma Companies 52

Pharma Companies Small Molecule Science Disease 52

Drug Patent Watch

JANUARY 9, 2025

Enter the Contract Development and Manufacturing Organization (CDMO) a lifeline for many startups looking to bring their innovative therapies to market. The pharmaceutical landscape is evolving rapidly, with small and medium-sized biotech companies increasingly taking center stage in innovation.

Compliance 52

Compliance Drug Development Pharma Companies Therapies 52

The Pharma Data

AUGUST 20, 2020

It has since expanded nationwide, threatening an important market for many Big Pharma players. . Companies such as AstraZeneca, Sanofi and Eli Lilly have managed to keep business under the aggressive procurement program, but they had to live with major discounts. . It’s not a completely unforeseen shift, though. Source link.

Pharma Companies 52

Pharma Companies International Marketing Drugs 52

H1 Blog

JUNE 7, 2023

Clinical trial success is a key factor for pharma companies when designing and recruiting patients into trials. This data will be invaluable in identifying potential contacts for marketing efforts, allowing the Foundation to effectively reach out to physicians who are most likely to be interested in their initiatives.

Trials 52

Trials Clinical Trials Pharma Companies Clinical Development 52

H1 Blog

JULY 30, 2024

This crucial inclusion of diverse populations through enrollment accuracy creates a direct correlation to operational efficiency, allowing for a quicker go-to-market process, a reduction in costly mistakes, and a more robust alignment to overall FDA requirements.

FDA 59

FDA Clinical Trials Compliance Pharma Companies 59

The Pharma Data

NOVEMBER 27, 2020

This week, another pharma company revealed a new technology device that can detect if a patient is infectious or not, while the Russian government published results of its Sputnik V vaccine, claiming it is more than 95 per cent efficient 42 days after the first dose. Save your seat at IDBS’s upcoming webinar.

Virus 52

Virus Vaccine International Immune Response 52

The Pharma Data

JULY 2, 2023

With nearly two decades of experience in sales, marketing and omnichannel excellence, and organizational transformation, Shigeto brings valuable technology-focused asset development and holistic marketing knowledge to Syneos Health. He is a dedicated team builder and is well-versed in people and change management. “As

Pharma Companies 40

Pharma Companies Marketing Therapies 40

The Pharma Data

DECEMBER 4, 2020

The companies have filed a request for Emergency Use Authorization with the US Food and Drug Administration and have submitted the final Conditional Marketing Authorization Application following rolling submissions with the European Medicines Agency and several other regulatory agencies around the world. Save your free seat now.

Vaccine 52

Vaccine Pharma Companies Science Trials 52

ACTO

NOVEMBER 25, 2024

“Our ambition is to become the first pharma company powered by artificial intelligence at scale, giving our people tools and technologies that focus on insights and allow them to make better everyday decisions. … Learn more about LAICA RepAssist by ACTO – the only AI Knowledge Assistant built for pharma field reps!

Clinical Trials 52

Clinical Trials Trials Pharma Companies Pharmaceuticals 52

H1 Blog

DECEMBER 11, 2024

While this approach aims to improve ROI before potential price controls kick in, it complicates trial design and recruitment, increasing the time it takes to get treatments to market. Furthermore, as pharma looks to offset future price controls, the prices of new drugs will likely spike.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

H1 Blog

JULY 5, 2023

From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market. The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials.

Clinical Trials 52

Clinical Trials Drugs Trials Drug Development 52

Alta Sciences

APRIL 5, 2024

Watch Altasciences in "Flipping the Drug Development Industry on Its Head" A Brief History of the CRO Market Contract Research Organizations (CROs) first entered the pharma world in the 1970s. CROs have historically functioned as auxiliaries to pharma companies, conducting the work sponsors can’t do in-house.

Drug Development 52

Drug Development Pharma Companies Marketing Drugs 52

The Pharma Data

NOVEMBER 9, 2020

To learn how your pharma company can progress to the next stage in the digital transformation journey, join Pharma IQ’s one-day masterclass alongside SGK Health as we dive into why authentic human-centric experiences are foundational to a brand’s existence and the successful implementation of a digital marketing strategy.

Vaccine 52

Vaccine Pharma Companies Science Trials 52

H1 Blog

NOVEMBER 15, 2023

The compensation provided to KOLs should also be fair-market value for their time and effort, and not an inducement for them to prescribe or recommend specific products. Furthermore, the interactions between life sciences companies and KOLs should be transparent and properly documented.

Compliance 59

Compliance Science Regulations Pharmaceutical Companies 59

Altus Drug Development

JUNE 28, 2022

This can drastically reduce the time and money it takes for a repositioned drug to reach the market. By using publicly available data, the researchers concluded that the median cost of bringing a new medicine to the market is $1.3 The restrictively high costs of drug development hinder the efforts of many pharmaceutical companies.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceuticals Doctors Treatment 52

The Pharma Data

JANUARY 31, 2021

During his tenure, Evotec established itself as a leading drug discovery and development company with a particular focus on precision medicine through early adoption of paradigm-shifting technologies such as iPSC-based drug discovery, industrialised multi-omics, and artificial intelligence-driven data analytics throughout the drug discovery process.

Science 52

Science Government Medical Schools Pharma Companies 52

PerkinElmer

FEBRUARY 18, 2021

Dr. Eckelt conducted 23 hour-long, 1:1 interviews over five months in 2020 to gather market insights on how the top 20 Pharma are increasing productivity, efficiency, and speed of drug discovery in the short and long-term. Pharma companies must improve productivity and efficiency amidst rising R&D costs.

Biochemical Assays 52

Biochemical Assays Drugs Small Molecule Pharma Companies 52

The Premier Consulting Blog

OCTOBER 21, 2024

However, the challenges surrounding confirmatory trials often revolve around delays and the complexities of conducting them once a drug has already hit the market. This decision, communicated in November 2022, delayed the BLA submission as the confirmatory trial needs to reach full enrollment before submission of the marketing application.

Trials 52

Trials FDA Clinical Trials Pharma Companies 52

H1 Blog

JUNE 26, 2024

Worldwide Clinical Trials is a leading full-service global CRO (contract research organization) working with biotech and pharma to create customized solutions. Perez spoke about the opportunities and challenges in health equity and the role of pharma companies and CROs to drive more equitable research.

Clinical Trials 59

Clinical Trials Trials FDA Pharma Companies 59

Predictive Oncology

FEBRUARY 7, 2023

Because pharma companies can’t predict which early-stage drug candidates will succeed, they end up playing a “numbers game,” according to Bush, by advancing multiple compounds. What happens if we are able to provide information to the pharmaceutical company that doubles that [and] one in 10 molecules actually make it?”

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

Vial

FEBRUARY 19, 2024

By that design, the sum of all parts is designed to solve problems of the current ADCs that are in the market for approval that have quite a bit of a toxicity profile and decreased efficacy potential. That by itself is really important to balance between the commercial, the market conditions, the drug development, and benefits for patients.

Small Molecule 52

Small Molecule Therapies Treatment Science 52

The Pharma Data

NOVEMBER 5, 2020

By a separate press release, the Company has today announced its intention to distribute the BUPI project to the shareholders of Moberg Pharma through a Lex Asea distribution with a subsequent listing on Nasdaq First North Growth Market during the Q1 of 2021. Other expenses for the Company’s operations.

Marketing 40

Marketing Production Regulations Pharma Companies 40

BioPharma Drive: Drug Pricing

JULY 8, 2025

Though those collaborations are “years away” from hitting the market, Roche sees “high potential” in pursuing those targets, said Boris Zaïtra, the head of corporate business development at Roche, in an interview earlier this year.

Targeted Protein Degradation 138

Targeted Protein Degradation Small Molecule Disease Therapies 138

Drug Target Review

MAY 26, 2025

By improving the ability to track and analyse viral aggregates, Refeyn’s technology helps manufacturers optimise the release of gene therapies, which in turn accelerates their journey to clinical trials and ultimately to market. Even large pharmaceutical companies often rely on CROs for their expertise and resources.

Drug Development 52

Drug Development Drugs Therapies Pharmaceuticals 52

Drug Target Review

SEPTEMBER 5, 2024

However, my goal was all the time to work with drug development in the pharma industry, so I moved on and started that journey in 1992 when I took on a role as Clinical Research Manager at AstraHässle, a mid-size Swedish pharma company. I experienced challenges in cultural differences working with US, UK, Japan, and China.

Pharma Companies 111

Pharma Companies Licensing Licensing Disease 111

The Pharma Data

OCTOBER 20, 2020

MD Anderson has historically collaborated with biotechs and pharma companies to conduct cancer therapy research. This is where biotechs are essential to take promising discoveries from the research lab into a product that can be tested, approved and taken to market. But now they’ll be choosing the therapies themselves. .

Clinical Trials 52

Clinical Trials Therapies Pharma Companies Trials 52